U-87 MG-CAS9 cell line

location： Home > Products > Cas9 Stable Cell Lines > U-87 MG-CAS9

Skeleton, Articulus, Soft Tissue, Derma System

Ocular, Otolaryngologic and Oral System

Skeleton, Articulus, Soft Tissue, Derma System

Ocular, Otolaryngologic and Oral System

Skeleton, Articulus, Soft Tissue, Derma System

Ocular, Otolaryngologic and Oral System

Skeleton, Articulus, Soft Tissue, Derma System

Ocular, Otolaryngologic and Oral System

Cell Monoclonal Culture Medium

Monoclone Genotype Validation Kit

U-87 MG-CAS9 Order

Catalog#

YC-C028-Cas9-H

Size

1*10^6

Transfection Culture Medium

Transfection Culture Medium-M

Storage conditions

Shipped on dry ice; Store in liquid nitrogen

Datasheet

Order

Detailed Product Information

Product category

Cas9 Stable Cell Lines

cell name

U-87 MG-CAS9

Morphology

Epithelial-like, adherent

Passage ratio

1:3~1:4

Species

Human

Expression gene

Cas9

Resistance gene

hygro

Construction method

Lentivirus

Mycoplasma test

negative

Culture method

90%DMEM+10% FBS

Description

Use Cas9 gene expressing lentivirus constructed by Ubigene to infect the U-87 MG cell line， screen the cells based on the resistance marker and the optimal antibiotic screening concentration explored in advance, resulting in a U-87 MG-CAS9 cell line that can maintain long-term, stable and high expression.

Product Validation Data（RT-QPCR）

Sample Name	Target Name	Cт Mean	ΔCт
U-87 MG-CAS9	Cas9	16.77473450	1.18480969
U-87 MG-CAS9	h-actin-B	15.58992481	1.18480969
U-87 MG	Cas9	36.17204666	20.33946323
U-87 MG	h-actin-B	15.83258343	20.33946323

Cutting Efficiency Validation

U-87 MG-CAS9 cell line Product Validation Data（RT-QPCR）

Note: The above figure shows the sequencing peaks of the U-87 MG-CAS9 stable cell pool which is electroporated by CHD4 gene targeting gRNA plasmid, after 48h antibiotic screening. The red arrow indicates the position where the nested peak appears, which shows that the genotype of the target site is significantly changed due to the cutting. Therefore, it indicates that Cas9 nuclease is successfully expressed.

STR Profile

Loci	STR Info (Sample Cell) Sample Cell Line:U-87 MG			STR Info (Cell bank) Cell Line:U-87MG
Loci	Allele1	Allele2	Allele3	Allele1	Allele2	Allele3
D5S818	11	12		11	12
D13S317	8	11		8	11
D7S820	8	9		8	9
D16S539	12	12		12	12
VWA	15	17		15	17
TH01	9.3	9.3		9.3	9.3
AMEL	X	X		X	X
TPOX	8	8		8	8
CSF1PO	10	11		10	11

* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases

Product Advantage

Easy to use：Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
01
High-efficient KO：These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
02
High-quality cell：Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
03

Related Popular Products

KO Cell Lines

SLC7A11 Knockout cell line (U-87 MG)
inquiry More details

Organism: Human

Gene Name: SLC7A11

Gene ID: 23657

Size: 1*10^6

Catalog#: YKO-H995

YKO-H995(U-87 MG)
HMOX1 Knockout cell line (U-87 MG)
inquiry More details

Organism: Human

Gene Name: HMOX1

Gene ID: 3162

Size: 1*10^6

Catalog#: YKO-H993

YKO-H993(U-87 MG)
NFE2L2 Knockout cell line (U-87 MG)
inquiry More details

Organism: Human

Gene Name: NFE2L2

Gene ID: 4780

Size: 1*10^6

Catalog#: YKO-H992

YKO-H992(U-87 MG)

Related Popular Products

KO Cell Lines

SLC7A11 Knockout cell line (U-87 MG)

Organism: Human

Gene Name: SLC7A11

Gene ID: 23657

Size: 1*10^6

Catalog#: YKO-H995

inquiry More details
HMOX1 Knockout cell line (U-87 MG)

Organism: Human

Gene Name: HMOX1

Gene ID: 3162

Size: 1*10^6

Catalog#: YKO-H993

inquiry More details
NFE2L2 Knockout cell line (U-87 MG)

Organism: Human

Gene Name: NFE2L2

Gene ID: 4780

Size: 1*10^6

Catalog#: YKO-H992

inquiry More details